Skip Navigation

Immunization and Infectious Diseases

Measles, 1998–2008

Decrease desired

IID-1.4 graph

Objective IID-1.4

SOURCE: National Notifiable Diseases Surveillance System (NNDSS), CDC/PHSIPO.
NOTE: Data are for the number of confirmed U.S.-acquired measles cases.

In 2008, 115 cases of U.S.-acquired measles were confirmed, more than two and a half times the number of cases in 2005, 42.


Vaccination of children 19–35 months—At least 3 doses hepatitis B vaccine, 2011

2020 Target: 90 percent

Increase desired

IID-7.3 graph

Objective IID-7.3

SOURCE: National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS.
NOTE: Data are for the proportion of children aged 19–35 months who had received at least 3 doses of the hepatitis B antigen.

In 2011, hepatitis B vaccination rates for all states were above 82%. Thirty-four states had over 90% vaccination coverage.


Vaccination of children 19–35 months—At least 1 dose measles-mumps-rubella (MMR) vaccine, 2011

2020 Target: 90 percent

Increase desired

IID-7.4 graph

Objective IID-7.4

SOURCE: National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS.
NOTE: Data are for the proportion of children aged 19–35 months who had received at least 1 dose of measles-mumps-rubella (MMR) vaccine.

In 2011, measles-mumps-rubella (MMR) vaccination rates for all states were above 85%. Thirty-five states had over 90% vaccination coverage.


Vaccination of children 19–35 months—At least 4 doses pneumococcal conjugate vaccine (PCV), 2011

2020 Target: 90 percent

Increase desired

IID-7.7 graph

Objective IID-7.7

SOURCE: National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS.
NOTE: Data are for the proportion of children aged 19–35 months who had received at least 4 doses of pneumococcal conjugate vaccine (PCV).

In 2011, pneumococcal conjugate vaccination (PCV) rates varied among the states. Only Connecticut, Nebraska, Rhode Island, and Wisconsin had over 90% vaccination coverage.


Recommended vaccines, adolescents, 2008

Increase desired

IID-11.1 through 11.4 graph

Objectives IID-11.1 through IID-11.4

SOURCE: National Immunization Survey—Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS.
NOTE: Data are for the proportion of adolescents aged 13–15 years who had received the recommended Tdap booster (tetanus-diptheria-acellular pertussis; 1 or more doses; objective IID-11.1), varicella vaccine (excluding children who had had varicella; at least 2 doses; objective IID-11.2), and MCV (meningococcal conjugate vaccine; 1 or more doses; objective IID-11.3), as well as the recommended HPV vaccine for females (human papillomavirus; 3 or more doses; objective IID-11.4).
I = 95% confidence interval.

In 2008, 46.7% of adolescents aged 13–15 years received the recommended tetanus-diphteria-acellular pertussis (Tdap) booster vaccination, 36.7% received the recommended varicella vaccination, 43.9% received the recommended meningococcal conjugate (MCV) vaccination, and 16.6% of females aged 13–15 years received the recommended human papillomavirus (HPV) vaccination. The Healthy People 2020 targets for these 4 objectives are 80% for Tdap, MCV, and HPV, and 90% for varicella.


Tuberculosis (TB), 1999–2008

Decrease desired

IID-29 graph

Objective IID-29

SOURCE: National Tuberculosis (TB) Surveillance System, CDC/NCHHSTP.
NOTES: Data are the number of new cases of tuberculosis per 100,000 that were reported to the CDC by local health departments in the 50 States and the District of Columbia. Patients were asked to select one or more races. The single race categories include persons for whom only one racial group was recorded. Persons of Hispanic origin may be of any race.

Despite the overall decline in new TB cases, the rate of new TB cases remains higher in 2008 among the Asian, Native Hawaiian or Other Pacific Islander, and non-Hispanic black populations than among other racial and ethnic groups.

Back to Top

Read A User’s Guide to the National Snapshots